Xencor, Inc.
NASDAQ:XNCRBiotechnology
Healthcare
$34.01 -1.03%
-$0.13 today
- Market cap
- $2.55B
- Beta
- 0.93
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$2.29
52W Low $6.92High $18.69
Volume 1.09M
Average 0.80M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$135.12M
FY 2025 · Annual
Investing Cash Flow
$139.99M
FY 2025 · Annual
Financing Cash Flow
$8.23M
FY 2025 · Annual
-95.8% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 82.63M | (55.18M) | (133.13M) | (236.54M) | (91.92M) |
| Depreciation & Amortization | 7.49M | 8.8M | 11.5M | 12.11M | 10.51M |
| Deferred Income Tax | (18.97M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 36.98M | 48.91M | 0 | 53.28M | 43.23M |
| Change in Working Capital | (102.6M) | 48.87M | 19.13M | (40.4M) | 47.45M |
| Accounts Receivables | (54.94M) | 36.86M | 19.83M | (32.67M) | 28.73M |
| Inventory | 1.4M | 0 | 0 | 0 | 0 |
| Accounts Payables | 5.05M | (3.91M) | 3.83M | 2.85M | (3.95M) |
| Other Working Capital | (54.11M) | 15.92M | (4.53M) | (10.57M) | 22.67M |
| Other Non-Cash Items | (22.38M) | (26.91M) | 24.58M | 9.36M | (144.39M) |
| Operating Cash Flow | (16.85M) | 24.49M | (77.93M) | (202.19M) | (135.12M) |
| Capital Expenditures | (15.98M) | (43.4M) | (18.45M) | (6.1M) | (3.15M) |
| Acquisitions (Net) | (2.66M) | 0 | 501K | 0 | 0 |
| Purchases of Investments | (509.6M) | (387.93M) | (782.91M) | (595.05M) | (298.9M) |
| Sales of Investments | 485.15M | 306.61M | 693.09M | 596.66M | 427.64M |
| Other Investing Activities | (3.16M) | 90K | 0 | (3.38M) | 14.39M |
| Investing Cash Flow | (46.25M) | (119.73M) | (110.57M) | (7.87M) | 139.99M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 28.92M | 0 | 5.39M | 201.26M | 9.96M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 14.12M | 5.7M | 183.33M | (4.1M) | (1.73M) |
| Financing Cash Flow | 43.04M | 5.7M | 188.72M | 197.15M | 8.23M |
| Effect of Forex Changes | 0 | 0 | (380K) | 0 | 0 |
| Net Change in Cash | (20.06M) | (89.54M) | (152K) | (12.91M) | 13.1M |
| Free Cash Flow | (32.83M) | (18.92M) | (96.37M) | (208.29M) | (138.27M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$91.9M
+ D&A$10.5M
+ Stock-Based Comp$43.2M
+ Deferred Tax$0
+ Working Capital$47.5M
- Other Non-Cash-$144.4M
= Operating Cash Flow-$135.1M
- Capex-$3.1M
= Free Cash Flow-$138.3M
Analysis
FY2025 free cash flow is -$138.3M. FCF conversion is 150.4% of net income. Operating cash flow was -$135.1M, with capex of -$3.1M. The largest bridge item is Other Non-Cash at -$144.4M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 6, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 5, 2026 |
Does XNCR generate free cash flow?
Xencor, Inc. (XNCR) generated -$138.27M of free cash flow in fiscal 2025.
How much operating cash flow does XNCR produce?
Operating cash flow was -$135.12M, before capital expenditures of $3.15M.
Continue the stock analysis
Jump to another research area for this company.